For example, MLL-rearranged infant ALL 5-years event-free survival (EFS) is only 20–50%, in comparison to over 60% for those with wild-type MLL (Hilden et al., 2006; Pieters et al., 2019). Here, KMT2A is linked to acute lymphoblastic leukemia.